Creon (pancrelipase), produced by drug maker Solvay, obtained from pig pancreas glands, can replace pancreatic enzymes normally excreted by the pancreas. Study results indicate the treatment’s effectiveness in relieving gastrointestinal effects of a lack of such enzymes caused by certain disorders, like cystic fibrosis. The possibility of viral contamination remains a concern and needs to be addressed in the drug’s label, according to an FDA official on Dec. 2^nd.